Previous 10 | Next 10 |
2024-04-26 06:36:00 ET 3 Top Tips to Spotting Uptrends With Penny Stocks Spotting uptrends in penny stocks is a key skill for investors looking to capitalize on the potential high returns these stocks can offer. Recognizing when penny stocks are on an upward trajectory involves understa...
A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 1.6% to $12 on volume of 162,538,711 shares Safe & Green Holdings Corp. (SGBX) rose 52.0% to $0.219 on volume of 135,670,644 shares Tesla Inc. (TSLA) rose 5.0% to $170.18 on volume of 124,333,134 shares...
2024-04-25 13:06:40 ET Gainers: Loar Holdings ( LOAR ) +63% . Safe & Green Holdings Corp ( SGBX ) +61% . YY Group Holding Limited Class A Ordinary Shares ( YYGH ) +50% . Barfresh Food Group ( BRFH ) +40% . Processa Pharmaceuticals ( ...
Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) is one today's most active stocks by volume. So far today, approximately 43.93M shares of Processa Pharmaceuticals, Inc. have been exchanged, as compared to an average 30-day volume of 428.53k shares. Processa Pharmaceuticals, Inc., a clinical stag...
A look at the top 10 most actives in the United States Safe & Green Holdings Corp. (SGBX) rose 52.1% to $0.2192 on volume of 34,842,044 shares Processa Pharmaceuticals Inc. (PCSA) rose 46.9% to $2.38 on volume of 31,858,013 shares PROSHARES TRUST (SQQQ) rose 5.0% to $12.4002 on volume...
2024-04-25 10:00:28 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance BofA watched clients retract $2B last week as the S&P dropped ...
2024-04-25 08:20:16 ET Barfresh Food Group, Inc. (BRFH) Q4 2023 Earnings Call Transcript POET: 2024 Could Be The Year For The Tide To Turn Processa Pharmaceuticals prices discounted stock and warrants offering to raise $7M Seeking Alpha’s Quant Rating on B...
Processa Pharmaceuticals (NASDAQ: PCSA) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for more patients suffering from cancer, participated at this year’s annual American Association for Canc...
NGC-Cap demonstrated greater 5-FU exposure than monotherapy capecitabine at a significantly lower dose with a favorable clinical safety profile NGC-Cap holds potential for improved efficacy in more patients due to an increase in distribution of 5-FU to cancer cells Phase 1b study ...
A look at the top 10 most actives in the United States Marin Software Incorporated (MRIN) rose 126.3% to $0.6497 on volume of 228,672,822 shares PROSHARES TRUST (SQQQ) rose 2.7% to $10.9 on volume of 177,760,238 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 4.9% to $3.43 ...
News, Short Squeeze, Breakout and More Instantly...
Processa Pharmaceuticals Inc. Company Name:
PCSA Stock Symbol:
OTCMKTS Market:
Processa Pharmaceuticals Inc. Website:
Processa (NASDAQ: PCSA) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, today announced positive efficacy results from the preliminary evaluation of its recently completed Phase 1b clinical trial. The...
Eight of 12 evaluable patients (66.7%) had progression-free survival (PFS) ranging from 5 to 11 months At the highest NGC-Cap dose, all three evaluable patients had PFS with two partial responses (PR) and one stable disease (SD) For all NGC-Cap doses, 5-Fluorouracil (5-FU) exp...
Processa Pharmaceuticals (NASDAQ: PCSA) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, will be represented at this month’s EF Hutton Annual Global Conference. According to the announcement, ke...